Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response-Reference-Cited by-同舟云学术

Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response

Published:2007-05-06 Issue:4 Volume:13 Page:373-379
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

GRINGERI A.¹,MUSSO R.²,MAZZUCCONI M. G.³,PISEDDU G.⁴,SCHIAVONI M.⁵,PIGNOLONI P.³,MANNUCCI P. M.¹,

Affiliation:

1. A. Bianchi Bonomi Haemophilia and Thrombosis Centre, Department of Medicine and Medical Specialties, University of Milan and IRCCS Maggiore Hospital, Mangiagalli and Regina Elena Foundation, Milan

2. Hemophilia Centre, Department of Hematology, Ferrarotto University Hospital, Catania

3. Hemophilia Centre, Department of Haematology and Cell Biotecnology, Policlinico Umberto I, La Sapienza University, Rome

4. Coagulation disorders Unit, SS Annunziata Hospital, Sassari;

5. Haemophilia Center, Transfusion Medicine Department, Policlinic Hospital, Bari, Italy

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2516.2007.01484.x

Reference37 articles.

1. Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group

2. Immune tolerance induction in patients with haemophilia A with inhibitors: a systematic review

3. MASSIVE FACTOR-VIII INFUSION IN HÆMOPHILIAC WITH FACTOR-VIII INHIBITOR, HIGH RESPONDER

4. Immune tolerance: a synopsis of the international experience

5. The German Registry of immune tolerance treatment in hemophilia – 1999 update;Lenk H;Haematologica,2000

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. von Willebrand factor modulates immune complexes and the recall response against factor VIII in a murine hemophilia A model;Blood Advances;2023-11-03

2. Immune Tolerance Induction (ITI) with a pdFVIII/VWF Concentrate (octanate) in 100 Patients in the Observational ITI (ObsITI) Study;TH Open;2022-04

3. Low‐dose immune tolerance induction therapy in children of Arab descent with severe haemophilia A, high inhibitor titres and poor prognostic factors for immune tolerance induction treatment success;Haemophilia;2021-11-19

4. Von Willebrand disease type 2N: An update;Journal of Thrombosis and Haemostasis;2021-03-26

5. octanate®: over 20 years of clinical experience in overcoming challenges in haemophilia A treatment;Therapeutic Advances in Hematology;2020-01